ImportRefusal LogoImportRefusal

Colgate Palmolive

⚠️ Moderate Risk

FEI: 1000330188 • Karachi, Sindh • PAKISTAN

FEI

FEI Number

1000330188

📍

Location

Karachi, Sindh

🇵🇰

Country

PAKISTAN
🏢

Address

Lakson Square, Building No. 2, Sarwar, , Karachi, Sindh, Pakistan

Moderate Risk

FDA Import Risk Assessment

35.8
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
5
Unique Violations
2/15/2019
Latest Refusal
11/4/2010
Earliest Refusal

Score Breakdown

Violation Severity
68.9×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
4.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

Refusal History

DateProductViolationsDivision
2/15/2019
63RAJ05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
336INCONSPICU
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/8/2011
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New York District Office (NYK-DO)
8/8/2011
53IC01DENTIFRICES (AEROSOL, LIQUID, TOOTHPASTES, TOOTHPOWDERS), WITHOUT FLUORIDE (ORAL HYGIENE PRODUCTS)
75UNAPPROVED
New York District Office (NYK-DO)
11/4/2010
63RAY04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
75UNAPPROVED
Philadelphia District Office (PHI-DO)

Frequently Asked Questions

What is Colgate Palmolive's FDA import refusal history?

Colgate Palmolive (FEI: 1000330188) has 4 FDA import refusal record(s) in our database, spanning from 11/4/2010 to 2/15/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Colgate Palmolive's FEI number is 1000330188.

What types of violations has Colgate Palmolive received?

Colgate Palmolive has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Colgate Palmolive come from?

All FDA import refusal data for Colgate Palmolive is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.